Share Penny Stock Geron Ends Advanced Cancer Study, Shifts Focus to Commercial Growth

Benzinga · GERN · October 28, 2026

Penny Stock Geron Ends Advanced Cancer Study, Shifts Focus to Commercial Growth

Stocks To Buy Now app

Get the app for more

Explore stock news, insights and company research.

Get the app →
Source: Benzinga ↗